1. Peery, AF, Crockett, SD, Barritt, AS et al. (2015) Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 149, 1731–1741.e3.
2. GBD 2015 Mortality and Causes of Death Collaborators (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459–1544.
3. Blachier, M, Leleu, H, Peck-Radosavljevic, M et al. (2013) The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58, 593–608.
4. Bedogni, G, Miglioli, L, Masutti, F et al. (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42, 44–52.
5. Wong, RJ, Aguilar, M, Cheung, R et al. (2015) Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148, 547–555.
6. Lazo, M, Hernaez, R, Eberhardt, MS et al. (2013) Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol 178, 38–45.
7. Matteoni, CA, Younossi, ZM, Gramlich, T et al. (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413–1419.
8. Godos, J, Federico, A, Dallio, M et al. (2017) Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection. Int J Food Sci Nutr 68, 18–27.
9. Chang, Y, Jung, H-S, Cho, J et al. (2016) Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am J Gastroenterol 111, 1133–1140.
10. Fierbinteanu-Braticevici, C, Sinescu, C, Moldoveanu, A et al. (2017) Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health. Cell Biol Toxicol 33, 5–14.
11. Marchesini, G, Brizi, M, Bianchi, G et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1844–1850.
12. Rivlin, RS (1994) Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr 13, 416–423.
13. Young, A, Cefaratti, C & Romani, A (2003) Chronic EtOH administration alters liver Mg2+ homeostasis. Am J Physiol Gastrointest Liver Physiol 284, G57–G67.
14. Gommers, LMM, Hoenderop, JGJ, Bindels, RJM et al. (2016) Hypomagnesemia in type 2 diabetes: a vicious circle? Diabetes 65, 3–13.
15. Turecky, L, Kupcova, V, Szantova, M et al. (2006) Serum magnesium levels in patients with alcoholic and non-alcoholic fatty liver. Bratisl Lek Listy 107, 58–61.
16. Song, Y, He, K, Levitan, EB et al. (2006) Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 23, 1050–1056.
17. Champagne, CM (2008) Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr Clin Pract 23, 142–151.
18. Song, Y, Manson, JE, Buring, JE et al. (2004) Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27, 59–65.
19. Dong, J-Y, Xun, P, He, K et al. (2011) Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 34, 2116–2122.
20. Wu, L, Zhu, X, Fan, L et al. (2017) Magnesium intake and mortality due to liver diseases: results from the Third National Health and Nutrition Examination Survey Cohort. Sci Rep 7, 17913.
21. Pittas, AG, Lau, J, Hu, FB et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017–2029.
22. Drouillet, P, Balkau, B, Charles, MA et al. (2007) Calcium consumption and insulin resistance syndrome parameters. Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Nutr Metab Cardiovasc Dis 17, 486–492.
23. Dai, Q, Shrubsole, MJ, Ness, RM et al. (2007) The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am J Clin Nutr 86, 743–751.
24. Dai, Q, Sandler, RS, Barry, EL et al. (2012) Calcium, magnesium, and colorectal cancer. Epidemiology 23, 504–505.
25. Dai, Q, Cantwell, MM, Murray, LJ et al. (2016) Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett’s oesophagus and oesophageal adenocarcinoma: a population-based case–control study. Br J Nutr 115, 342–350.
26. Dai, Q, Shu, X-O, Deng, X et al. (2013) Modifying effect of calcium/magnesium intake ratio and mortality: a population-based cohort study. BMJ Open 3, e002111.
27. Centers for Disease Control and Prevention (2011) NHANES 1988–1994: Hepatic/Gallbladder Ultrasound and Hepatic Steatosis Data Documentation, Codebook, and Frequencies. http://www.cdc.gov/nchs/nhanes/nhanes3/HGUHS.htm (accessed December 2016).
28. American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34, Suppl. 1, S62–S69.
29. Sjögren, A, Florén, CH & Nilsson, A (1988) Oral administration of magnesium hydroxide to subjects with insulin-dependent diabetes mellitus: effects on magnesium and potassium levels and on insulin requirements. Magnesium 7, 117–122.
30. Paolisso, G, Sgambato, S, Pizza, G et al. (1989) Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 12, 265–269.
31. He, K, Song, Y, Belin, RJ et al. (2006) Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr 1, 351–355.
32. Pagano, G, Pacini, G, Musso, G et al. (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35, 367–372.
33. Hruby, A, Meigs, JB, O’Donnell, CJ et al. (2014) Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged Americans. Diabetes Care 37, 419–427.
34. Da Silva, HE, Arendt, BM, Noureldin, SA et al. (2014) A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls. J Acad Nutr Diet 114, 1181–1194.
35. He, K, Liu, K, Daviglus, ML et al. (2006) Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113, 1675–1682.
36. Hardwick, LL, Jones, MR, Brautbar, N et al. (1991) Magnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate. J Nutr 121, 13–23.
37. Norman, DA, Fordtran, JS, Brinkley, LJ et al. (1981) Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest 67, 1599–1603.
38. Abrams, SA, Grusak, MA, Stuff, J et al. (1997) Calcium and magnesium balance in 9-14-y-old children. Am J Clin Nutr 66, 1172–1177.
39. Institute of Medicine, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (1997) Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academies Press.
40. Hoenderop, JGJ & Bindels, RJM (2005) Epithelial Ca2+ and Mg2+ channels in health and disease. J Am Soc Nephrol 16, 15–26.
41. Monnens, L, Starremans, P & Bindels, R (2000) Great strides in the understanding of renal magnesium and calcium reabsorption. Nephrol Dial Transplant 15, 568–571.
42. Guéguen, L & Pointillart, A (2000) The bioavailability of dietary calcium. J Am Coll Nutr 19, 2 Suppl., 119S–136S.
43. Green, JH, Booth, C & Bunning, R (2003) Acute effect of high-calcium milk with or without additional magnesium, or calcium phosphate on parathyroid hormone and biochemical markers of bone resorption. Eur J Clin Nutr 57, 61–68.
44. Nielsen, FH, Milne, DB, Gallagher, S et al. (2007) Moderate magnesium deprivation results in calcium retention and altered potassium and phosphorus excretion by postmenopausal women. Magnes Res 20, 19–31.